Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sub-study of SPYRAL AFFIRM: Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT)

NCT07115953 is registered in ClinicalTrials.gov with Medtronic Vascular as lead sponsor.

NCT NCT07115953
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07115953 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sub-study of SPYRAL AFFIRM: Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT)
Lead sponsor
Medtronic Vascular
Phase
Not applicable
Overall status
Recruiting
Start date
September 22, 2025
Completion date
December 31, 2029
Enrollment
130 (estimated)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, chronic kidney diseases, diabetes mellitus, hypertension, vascular diseases